Roche Holding AG
- Country
- ๐จ๐ญSwitzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00002273
- Locations
- ๐บ๐ธ
Roche Global Development - Palo Alto, Palo Alto, California, United States
A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 120
- Registration Number
- NCT00002374
- Locations
- ๐บ๐ธ
Ctr for Quality Care, Tampa, Florida, United States
๐บ๐ธAIDS Ctr, New York, New York, United States
๐บ๐ธPacific Oaks Med Ctr, Beverly Hills, California, United States
A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 150
- Registration Number
- NCT00002257
- Locations
- ๐จ๐ฆ
Saint Paul's Hosp, Vancouver, British Columbia, Canada
๐บ๐ธNew York Univ Med Ctr, New York, New York, United States
๐บ๐ธBeth Israel Deaconess Med Ctr, Boston, Massachusetts, United States
The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 28
- Registration Number
- NCT00002380
- Locations
- ๐บ๐ธ
Hoffmann - La Roche Inc, Nutley, New Jersey, United States
A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 40
- Registration Number
- NCT00002448
- Locations
- ๐บ๐ธ
Palo Alto Veterans Affairs Health Care System, Palo Alto, California, United States
๐บ๐ธUCLA Care Ctr, Los Angeles, California, United States
๐บ๐ธRobert Wood Johnson Med School/UMDNJ, New Brunswick, New Jersey, United States
A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 200
- Registration Number
- NCT00002222
- Locations
- ๐บ๐ธ
Cornell AIDS Clinical Trials Unit, New York, New York, United States
The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 400
- Registration Number
- NCT00002425
- Locations
- ๐บ๐ธ
Consumer Contact, Nutley, New Jersey, United States
Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00002025
- Locations
- ๐บ๐ธ
Roche Global Development - Palo Alto, Palo Alto, California, United States
A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 4000
- Registration Number
- NCT00002382
- Locations
- ๐บ๐ธ
Hoffmann - La Roche Inc, Nutley, New Jersey, United States
A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 24
- Registration Number
- NCT00002096
- Locations
- ๐บ๐ธ
Georgetown Univ Med Ctr, Washington, District of Columbia, United States
๐บ๐ธCtr for Special Immunology, Irvine, California, United States
๐บ๐ธUniv TX Galveston Med Branch, Galveston, Texas, United States